Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.64 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.37 |
| ▸ | PYGB | P11216 | 1/20 | 0.36 |
| ▸ | KDR | P35968 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL33302 | 1.00 | MAPK1 (0.64) | MAPK1NOD2ALDH1A1THRBLGALS8 | |
| SCHEMBL30987364 | 1.00 | MAPK1 (0.64) | MAPK1NOD2ALDH1A1THRBLGALS8 | |
| SCHEMBL16241536 | 1.00 | MAPK1 (0.64) | MAPK1NOD2ALDH1A1THRBLGALS8 | |
| SCHEMBL42791 | 1.00 | MAPK1 (0.64) | MAPK1NOD2ALDH1A1THRBLGALS8 | |
| SCHEMBL2728425 | 1.00 | MAPK1 (0.64) | MAPK1NOD2ALDH1A1THRBLGALS8 | |
| SCHEMBL16241534 | 1.00 | MAPK1 (0.64) | MAPK1NOD2ALDH1A1THRBLGALS8 | |
| SCHEMBL42792 | 1.00 | MAPK1 (0.64) | MAPK1NOD2ALDH1A1THRBLGALS8 | |
| SCHEMBL20533512 | 1.00 | MAPK1 (0.64) | MAPK1NOD2ALDH1A1THRBLGALS8 | |
| SCHEMBL22163862 | 1.00 | MAPK1 (0.64) | MAPK1NOD2ALDH1A1THRBLGALS8 | |
| Water SCHEMBL2557169 | 0.99 | MAPK1 (0.63) | MAPK1NOD2ALDH1A1THRBLGALS8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4135719-A1 | TREATMENT OF CORONAVIRUS INFECTIONS | TX Medic AB (SE) | 2023-02-22 | — | — | EP | disclosed |
| WO-2021211043-A1 | TREATMENT OF CORONAVIRUS INFECTIONS | TX MEDIC AB (SE) | 2021-10-21 | — | — | WO | disclosed |
| WO-2018085937-A1 | MANAGING SITE SPECIFIC IBD IMMUNOTHERAPIES | QU BIOLOGICS INC. (CA) | 2018-05-17 | — | — | WO | disclosed |
| WO-2017185180-A1 | THERAPEUTICALLY TRIGGERING AN INNATE IMMUNE RESPONSE IN A TARGET TISSUE | QU BIOLOGICS INC. (CA) | 2017-11-02 | — | — | WO | disclosed |
| EP-3132021-A2 | AMMONIA-OXIDIZING NITROSOMONAS EUTROPHA STRAIN D23 | Aobiome LLC (US) | 2017-02-22 | — | — | EP | disclosed |
| WO-2015160911-A2 | AMMONIA-OXIDIZING NITROSOMONAS EUTROPHA STRAIN D23 | AOBIOME LLC (US) | 2015-10-22 | — | — | WO | disclosed |
| CN-101306191-B | Use of TLR2 ligand PGN in treating metabolism syndrome | INST MATERIA MEDICA CAMS | 2013-01-16 | — | — | CN | disclosed |
| CN-101947213-B | Method for preparing microcapsules from peptidoglycan in lactic acid bacterial cell walls | UNIV HEILONGJIANG | 2011-10-12 | — | — | CN | disclosed |
| CN-101947213-A | Method for preparing microcapsules from peptidoglycan in lactic acid bacterial cell walls | UNIV HEILONGJIANG | 2011-01-19 | — | — | CN | disclosed |
| CN-101306191-A | Use of TLR2 ligand PGN in treating metabolism syndrome | INST MATERIA MEDICA CAMS (CN) | 2008-11-19 | — | — | CN | disclosed |